The term “memorability” refers to the likelihood that a particular stimulus, such as an object, face or sound, will be remembered by those exposed to it. Over the past few years, some psychology studies have been exploring the extent to which some stimuli are intrinsically more memorable than others, or in other words, whether people are generally more likely to remember them compared to other stimuli of the same type.

Researchers at the University of Chicago recently set out to specifically investigate the memorability of voices. Their findings, published in Nature Human Behaviour, suggest that some voices are more memorable than others and their memorability can be consistently predicted across different listeners.

“Research on intrinsic memorability—the consistencies in what people remember and forget—is a fairly new but active area of cognitive psychology,” Cambria Revsine, first author of the paper, told Medical Xpress. “Many studies from our lab and others have extensively explored this phenomenon over the past decade, finding that participants tend to remember the same images of faces, scenes, objects, and much more. However, no prior study to our knowledge has investigated the memorability of auditory stimuli.”

A team of neurologists, neuroradiologists and biomaterials specialists affiliated with several institutions in Spain has found that marathon runners undergo a reversible reduction in myelin in the brain during a race. In their study published in the journal Nature Metabolism, the group analyzed MRI scans of marathon runners before and after a race and then at later intervals to learn more about how participating in long races impacts the brain.

The editors at the journal have published a Research Briefing that outlines the work in the same issue and suggest that the team’s findings could influence the understanding of brain metabolism.

The researchers recruited 10 runners—eight male and two female—and performed MRI scans of their brains before they ran a 42K marathon. They administered a second scan 24 to 48 hours later. Two of the runners received an MRI two weeks later, and six runners were scanned two months after the race as a follow-up.

Research conducted by the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, and the Centers for Disease Control and Prevention reveals that 1 in 4 adults using prescription stimulants engaged in misuse, and nearly 1 in 10 met the criteria for prescription stimulant use disorder (PSUD).

Findings show that amphetamine users were more likely to experience PSUD than those prescribed methylphenidate. Increased prescribing rates, particularly among middle-aged women, were observed, yet this demographic exhibited lower misuse rates than younger adults.

Concerns over stimulant misuse have grown as prescribing rates for these medications, commonly used to treat attention-deficit/hyperactivity disorder (ADHD), have increased. Clinical practice guidelines for adult ADHD remain absent, leading to variations in diagnosis and treatment. Questions about appropriate use persist as research indicates both the protective benefits of ADHD pharmacotherapy and its potential risks, including misuse, overprescription, and development of use disorders.